← All reports

Novartis has suspended its cell therapy clinical trials due to patient fatalities.

PharmaceuticalsHealthcareClinical TrialsSep 1, 2026score 0.172 posts · 0 replies across 1 instances
The posts report that the pharmaceutical company Novartis has halted clinical trials for a cell therapy treatment. This decision follows reports of patient deaths during the study, highlighting safety concerns in advanced medical research.

Claims

Novartis has suspended its cell therapy clinical trials due to patient fatalities.
Parent: PharmaceuticalsEntity: NovartisSub-entity: cell therapy trialsImpact: negativeDate: Sep 1, 2026Target: Novartis cell therapy trials

Source posts

@[email protected]
Pharmaindustrie: Novartis stoppt nach Todesfällen Studien zu Zelltherapie https://www.handelsblatt.com/technik/medizin/pharmaindustrie-novartis-stoppt-nach-todesfaellen-studien-zu-zelltherapie/100251018.html?utm_campaign=feed-schlagzeilen&utm_source=flipboard&utm_medium=activitypub Gepostet in Schlagzeilen @schlagzeilen-Handelsblatt
0 boosts · 0 favs · 0 replies · Sep 1, 2026
@[email protected]
Pharmaindustrie: Novartis stoppt nach Todesfällen Studien zu Zelltherapie https://www.handelsblatt.com/technik/medizin/pharmaindustrie-novartis-stoppt-nach-todesfaellen-studien-zu-zelltherapie/100251018.html?utm_campaign=feed-technologie&utm_source=flipboard&utm_medium=activitypub Gepostet in Technologie @technologie-Handelsblatt
1 boosts · 0 favs · 0 replies · Sep 1, 2026